Poly-ADP-Ribose Binding Proteins
"Poly-ADP-Ribose Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that contain POLY-ADP RIBOSE BINDING MOTIFS. They include HISTONES and other proteins that function in DNA REPAIR, replication, gene transcription, and APOPTOSIS.
| Descriptor ID |
D000075223
|
| MeSH Number(s) |
D12.776.157.687 D12.776.660.720
|
| Concept/Terms |
Poly-ADP-Ribose Binding Proteins- Poly-ADP-Ribose Binding Proteins
- Binding Proteins, Poly-ADP-Ribose
- Poly ADP Ribose Binding Proteins
- pADPr-Binding Proteins
- pADPr Binding Proteins
|
Below are MeSH descriptors whose meaning is more general than "Poly-ADP-Ribose Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "Poly-ADP-Ribose Binding Proteins".
This graph shows the total number of publications written about "Poly-ADP-Ribose Binding Proteins" by people in this website by year, and whether "Poly-ADP-Ribose Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Poly-ADP-Ribose Binding Proteins" by people in Profiles.
-
Profiling of RNA-binding protein binding sites by in situ reverse transcription-based sequencing. Nat Methods. 2024 Feb; 21(2):247-258.
-
Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma. J Neurooncol. 2018 Nov; 140(2):317-328.
-
Bromodomain and hedgehog pathway targets in small cell lung cancer. Cancer Lett. 2016 Feb 28; 371(2):225-39.
-
Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1. JAMA Oncol. 2015 Dec; 1(9):1319-23.
-
Molecular profiling in gastric cancer: examining potential targets for chemotherapy. J Surg Oncol. 2014 Sep; 110(3):302-6.
-
Integrated genomic characterization of endometrial carcinoma. Nature. 2013 May 02; 497(7447):67-73.
-
Appendage expression driven by the Hoxd Global Control Region is an ancient gnathostome feature. Proc Natl Acad Sci U S A. 2011 Aug 02; 108(31):12782-6.
-
NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform. J Biol Chem. 2008 Aug 29; 283(35):23711-20.
-
Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet. 2007 Jan; 44(1):44-50.
-
Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression. J Clin Pathol. 2006 Dec; 59(12):1272-7.